25 Feb Vor Biopharma
Posted at 15:57h in
Robert Ang, President and CEO
April 12 | 11:30am | BioCentriq Ballroom
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.